Do probiotic or synbiotic preparations alleviate symptoms associated with constipation or irritable bowel syndrome?

Journal of Wound, Ostomy and Continence Nursing

Volumn 34, Issue 6, 2007, Pages 615-624

  Eddins, Carolyn ^a   Gray, Mikel ^b,c  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT; YOGHURT;

ARTICLE; CONSTIPATION; EVIDENCE BASED MEDICINE; HOSPITALIZATION; HUMAN; INTESTINE MUCOSA; IRRITABLE COLON; METHODOLOGY; MICROBIOLOGY; ORGANIZATION AND MANAGEMENT; PAIN; TREATMENT OUTCOME;

CONSTIPATION; EVIDENCE-BASED MEDICINE; HUMANS; INTESTINAL MUCOSA; IRRITABLE BOWEL SYNDROME; PAIN; PROBIOTICS; RESEARCH DESIGN; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOGURT;

EID: 36348942895     PISSN: 10715754     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.WON.0000299811.00910.f0     Document Type: Article

References (41)

1. Riordan SM, Kim R. Bacterial overgrowth as a cause of irritable bowel syndrome. Curr Opin Gastroenterol. 2006;22(6):669-673.
2. Leahy SC, Higgins DG, Fitzgerald GF, vin Sinderen D. Getting with bifidobacteria. J Appl Microbiol. 2005;98:1303-1315.
3. Sullivan A, Nord CE. Probiotics and gastrointestinal diseases. J Intern Med. 2005;257:78-92.
4. Berg RD. The indigenous gastrointestinal microflora. Trends Microbiol. 1996;4:430-445.
5. Fuller R. Probiotics in man and animals. J Appl Bacteriol. 1989;66:365-378.
6. FAO/WHO. Joint FAO/WHO expert consultation on evaluation of health and nutritional properties of probiotics in food. ftp://ftp.fao.org/es/esn/food/ wgreport2.pdf. Accessed August 9, 2007.
7. Schrezenmeir J, de Vrese M. Probiotics, prebiotics and synbiotics - approaching a definition. Am J Clin Nutr. 2001;(73)(supplement):361S- 364S.
8. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota. Introducing the concept of prebiotics. J Nutr. 1995;125:1401-1402.
9. Corthesy B, Gaskins HR, Mercenier A. Cross-talk between probiotic bacteria and the host immune system. J Nutr. 2007;137(3 Suppl 2):781S-790S.
10. Reid G, Hammond J. Probiotics: some evidence of their effectiveness. Can Fam Physician. 2005;51:1487-1493.
11. Scholz-Ahrens KE, Ade P, Marten B, Weber P, Timm W, Asil Y, Gluer CC, Schrezenmeir J. Prebiotics, probiotics, and synbiotics affect mineral absorption, bone mineral content, and bone structure. J Nutr. 2007;137(3 Suppl 2):838S-846S.
12. Barbara G, Stanghellini V, Brandi G, Cremon C, Di Nardo G, De Giorgio R, Corinaldesi R. Interactions between commensal bacteria and gut sensorimotor function in health and disease. Am J Gastroenterol. 2005;100(11):2560- 2568.
13. American Gastroenterological Association. American Gastroenterological Association medical position statement: guidelines on constipation. Gastroenterology. 2000;119(6):1761-1770.
14. Bliss DZ, Doughty DB, Heitkemper MM. Pathology and management of bowel dysfunction. In: Doughty DB, ed. Urinary and Fecal Incontinence: Current Concepts and Management. 3rd ed. St Louis, MO: Mosby/Elsevier; 2006:425-456.
15. Hamilton-Miller JM. Probiotics and prebiotics in the elderly. Postgrad Med J. 2004;80(946):447-451.
16. American Gastroenterological Association. American Gastroenterological Association medical position statement: irritable bowel syndrome. Gastroenterology. 1997;112(6):2118-2119.
17. Quigley EMM. Bacterial flora in irritable bowel syndrome: role in pathophysiology, implications for management. Am J Dig Dis. 2007;8(1):2-7.
18. Amenta M, Cascio MT, Di Fiore P, Venturini I. Diet and chronic constipation. Benefits of oral supplementation with symbiotic zir fos (Bifidobacterium longum W11 + FOS Actilight). Acta Biomed. 2006;77(3):157-162.
19. Koebnick C, Wagner I, Leitzmann P, Stern U, Zunft HJ. Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation. Can J Gastroenterol. 2003;17(11):655-659.
20. Ouwehand AC, Lagstrom H, Suomalainen T, Salminen S. Effect of probiotics on constipation, fecal azoreductase activity and fecal mucin content in the elderly. Ann Nutr Metab. 2002;46(3-4):159-162.
21. Benton D, Williams C, Brown A. Impact of consuming a milk drink containing a probiotic on mood and cognition. Eur J Clin Nutr. 2007;61:355-361.
22. Walker R, Buckley M. Probiotic Microbes: the scientific basis. Report of the American Society for Microbiology Colloquium; Nov 5-7, 2005; Baltimore, Maryland. American Society for Microbiology Web site. http://www.asm.org. Accessed August 28, 2007.
23. Tanaka R., Shimosaka K. Investigation of the stool frequency in elderly who are bed ridden and its improvements by ingesting bifidus yogurt. Nippon Ronen Igakkai Zasshi. 1982;19(6):577-582.
24. Umesaki Y. Modification of gastrointestinal function. In: Yakult Central Institute for Microbiological Research, ed. Lactobacillus Casei strain Shiroto. Tokyo: Yakult Honsha Ltd; 1999:118-128.
25. Salminen S, Salminen E. Lactulose, lactic acid bacteria, intestinal microecology and mucosal protection. Scand J Gastroenterol. 1997;(suppl):222:45-48.
26. Kajander K, Korpela R. Clinical studies on alleviating the symptoms of irritable bowel syndrome. Asia Pac J Clin Nutr. 2006;15(4):576-580.
27. Kajander K, Hatakka K, Poussa T, Färkkilä M, Korpela R. A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention. Aliment Pharmacol Ther. 2005;22:387-394.
28. Colecchia A, Vestito A, La Rocca A, Pasqui F, Nikiforaki A, Festi D. Symbiotic Study Group. Effect of a symbiotic preparation on the clinical manifestations of irritable bowel syndrome, constipation-variant. Results of an open, uncontrolled multicenter study. Minerva Dietol Gastroenterol. 2006;52(4):349-358.
29. Astegiano M, Pellicano R, Terzi E, Simondi D, Rizzetto M. Treatment of irritable bowel syndrome. A case control experience. Minerva Dietol Gastroenterol. 2006;52(4):359-363.
30. Kim YG, Moon JT, Lee KM, Chon NR, Park H. The effects of probiotics on symptoms of irritable syndrome. Korean J Gastroenterol. 2006;47(6):413-419.
31. Whorwell PJ, Altringer L, Morel J, Bond Y, Charbonneau D, O'Mahony L, Kiely B, Shanahan F, Quigley EM. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol. 2006;101(7):1581-1590.
32. Fan YJ, Chen SJ, Yu YC, Si JM, Liu B. A probiotic treatment containing Lactobacillus, Bifidobacterium and Enterococcus improves IBS symptoms in an open label trial. J Zhejiang Univ Sci. 2006;7(12):987-991.
33. O'Mahony L, McCarthy J, Kelly P, Hurley G, Luo F, Chen K, O'Sullivan GC, Kiely B, Collins JK, Shanahan F, Quigley EM. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology. 2005;128(3):541-551.
34. Kim HJ, Vazquez Roque MI, Camilleri M, Stephens D, Burton DD, Baxter K, Thomforde G, Zinsmeister AR. A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating. Neurogastroenterol Motil. 2005;17(5):687-696.
35. Niv E, Naftali T, Hallak R, Vaisman N. The efficacy of Lactobacillus reuteri ATCC 55730 in the treatment of patients with irritable bowel syndrome - a double blind, placebo-controlled, randomised study. Clin Nutr. 2005;24:925-931.
36. Bausserman M, Michail S. The use of Lactobacillus GG in irritable bowel syndrome in children: a double-blind randomized control trial. J Pediatr. 2005;147(2);197-201.
37. Tsuchiya J, Barreto R, Okura R, Kawakita S, Fesce E, Marotta F. Single-blind follow-up study on the effectiveness of a symbiotic preparation in irritable bowel syndrome. Chin J Dig Dis. 2004;5(4):169-174.
38. Bittner AC, Croffut RM, Stranahan MC, et al. Prescript-Assist probiotic-prebiotic treatment for irritable bowel syndrome: a methodologically oriented, 2-week, randomized, placebo-controlled, double-blind clinical study. Clin Ther. 2005;27:755-761.
39. Long ZR, Yu CH, Yang Y, Wang HN, Chi XX. Clinical observation on acupuncture combined with microorganism pharmaceutical preparations for treatment of irritable bowel syndrome of constipation type. Zhongguo Zhen Jiu. 2006;26(6):403-405.
40. Adler SN. The probiotic agent Escherichia coli M-17 has a healing effect in patients with IBS with proximal inflammation of the small bowel. Dig Liver Dis. 2006;38(9):713.
41. Drisko J, Bischoff B, Hall M, McCallum R. Treating irritable bowel syndrome with a food elimination diet followed by food challenge and probiotics. J Am Coll Nutr. 2006;25(6):514-522.